Ex-Allergan team at Bonti raises $15.5M for another neurotoxin; Shire commits to publishing in open access journals only
→ Fauad Hasan and his team of fellow former Allergan execs at Bonti has raised $15.5 million in Series C funding for the development of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
